EIKO Lifesciences

63.09
-1.71
(-2.64%)
Market Cap
86.55 Cr
EPS
1.62
PE Ratio
48.00
Dividend Yield
0.00 %
Industry
Chemicals
52 Week High
74.88
52 Week Low
42.00
PB Ratio
1.57
Debt to Equity
0.38
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
3,080.50
#1 1,56,689.25
75.62
13,140.30
5.69
#1 2,110
40.49
64.46
3,236.90
95,949.75
76.69
14,825.80
#1 12.13
1,251
24.61
65.97
3,512.50
38,584.81
70.84
4,737.00
-25.09
523
89.11
43.06
1,960.60
26,741.22
#1 38.56
8,281.93
-3.26
724
-20.24
51.71
498.20
24,603.58
44.77
4,664.30
10.33
555
34.98
61.36
4,889.30
24,238.05
83.77
2,349.38
0.37
289
34.94
69.01
7,680.50
22,612.74
45.94
5,583.35
-13.69
534
#1 121.26
64.80
5,120.50
22,164.41
48.60
#1 15,246.30
-
462
-83.27
58.61
1,949.90
20,213.76
49.93
2,248.17
-8.77
424
18.04
62.10
476.40
17,270.46
52.88
7,271.00
-3.61
312
-27.27
58.39
Forecast
Actual
Growth Rate
Revenue Growth
141.86 %
Net Income Growth
350.00 %
Cash Flow Change
-306.25 %
ROE
1,894.67 %
ROCE
996.13 %
EBITDA Margin (Avg.)
185.76 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
1
1
1
1
2
4
3
1
1
1
11
8
8
12
Expenses
1
1
1
2
3
6
5
2
0
1
10
8
7
10
EBITDA
-0
-0
-0
-0
-0
-2
-1
-1
0
0
1
1
1
2
Operating Profit %
-9 %
-14 %
-14 %
-26 %
-18 %
-44 %
-42 %
-148 %
25 %
-6 %
4 %
5 %
9 %
12 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-0
-0
-0
-1
-1
-2
-2
-1
0
-0
1
0
1
2
Tax
-0
-0
0
-0
-0
-1
-0
-0
0
0
0
0
0
0
Net Profit
-0
-0
-0
-0
-0
-1
-1
-1
0
-0
0
0
0
1
EPS in ₹
-0.25
-0.26
-0.22
-0.58
-0.50
-1.87
-1.55
-1.08
0.17
-0.14
0.29
0.22
0.32
0.80

Balance Sheet

Balance Sheet
2018
2019
2020
2025
Total Assets
11
9
12
66
Fixed Assets
2
2
2
23
Current Assets
6
4
5
33
Capital Work in Progress
0
0
0
0
Investments
3
2
0
6
Other Assets
6
6
10
0
Total Liabilities
11
9
12
66
Current Liabilities
5
4
9
6
Non Current Liabilities
1
0
2
3
Total Equity
6
5
1
57
Reserve & Surplus
2
1
-1
43
Share Capital
4
4
4
14

Cash Flow

Cash Flow
2017
2018
2019
2020
Net Cash Flow
0
0
-1
-0
Investing Activities
0
0
-0
-1
Operating Activities
0
0
0
-0
Financing Activities
0
0
-1
1

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 May 2025 50.40 50.44
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 56.54 49.47
19 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 Oct 2024 70.44 63.26
28 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Sept 2024 58.21 58.00
07 Jul 2023 RIGHTS Rights
2:3
07 Jul 2023 62.64 60.38
01 Mar 2021 CHANGE OF NAME Change Of Name
NA
01 Mar 2021 41.20 41.20

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20118 days ago
Closure of Trading Window8 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
Revised Financial Results For Quarter And Year Ended 31St March 2025May 14, 2025
Revise Outcome Of Board Meeting Dated 14.05.2025May 14, 2025
Appointment Of Secretarial AuditorMay 14, 2025
Appointment Of Internal AuditorMay 14, 2025
Results For Quarter And Year Ended 31St March 2025May 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated 14.05.2025May 14, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 14, 2025
Board Meeting Intimation for Approval Of Financial Results And Other AgendasMay 07, 2025
Submission Of Initial And Annual Disclosure As Per SEBI Circular- - Fund Raising By Issuance Issuance Of Debt Securities By Large CorporatesApr 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 28, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 28, 2025
Closure of Trading WindowMar 26, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 18, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 18, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 17, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 13, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 12, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 11, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 08, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 07, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 05, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 04, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 03, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 27, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 27, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 21, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 19, 2025
Newspaper PublicationFeb 14, 2025
Integrated Filing (Financial)Feb 12, 2025
Nil Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 12, 2025
Financial Results For Quarter And Nine Months Ended 31St December 2024Feb 12, 2025
Board Meeting Outcome for Outcome Of Board MeetinngFeb 12, 2025
Board Meeting Intimation for Meeting Of Board Of Directors Of The Company Is Scheduled To Be Held On Wednesday 12Th February 2025 To Consider And Approve Unaudited Financial Results (Standalone & ConsJan 24, 2025
Outcome Of The Meeting Of The Rights Issue Committee Of Board Of Directors Of Eiko Lifesciences Limited (Company) Held On Friday 24Th January 2025Jan 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 18, 2024
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsDec 18, 2024
Final Reminder Cum Forfeiture Call Notice To The Holders Of Partly Paid-Up Equity Shares (ISIN: IN9666Q01014), Who Have Not Paid The First And Final Call Money.Dec 17, 2024
Revised Outcome Of Right Issue Committee MeetingNov 25, 2024
Outcome Of The Meeting Of The Right Issue Committee Of Board Of Director Held On 25Th September, 2024Nov 25, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Nov 25, 2024
Board Meeting Intimation for Discussion On Final Reminder And Forfeiture Of The Partly Paid-Up Equity Shares On Which Call Money Has Not Been Received By The Company.Nov 19, 2024
Post-Offer Public AnnouncementNov 12, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 05, 2024
Announcement under Regulation 30 (LODR)-Diversification / DisinvestmentNov 05, 2024

Technical Indicators

RSI(14)
Overbought
80.83
ATR(14)
Volatile
3.52
STOCH(9,6)
Neutral
62.49
STOCH RSI(14)
Overbought
87.37
MACD(12,26)
Bullish
1.24
ADX(14)
Weak Trend
13.47
UO(9)
Bearish
59.38
ROC(12)
Uptrend And Accelerating
29.34
WillR(14)
Overbought
-6.14